Tokyo University: Clinical Trials

54 trials sponsored by Tokyo University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 10 unknown, 5 recruiting, 5 terminated. 20 Not applicable, 19 Phase 2, 17 Phase 1, 3 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 14, Not yet recruiting 2, Recruiting 2, Enrolling by invitation 1, Unknown 1
Phase 219Completed 8, Unknown 6, Terminated 5
Phase 117Completed 9, Terminated 5, Unknown 3
Phase 43Completed 3
Phase 32Completed 1, Recruiting 1

Follow Tokyo University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MSA-01 in Multiple System Atrophy
MSA-01, Placebo - Multiple System Atrophy (MSA)
Phase 3RecruitingTokyo University1402026-02-092026-03-04
Pilot Cluster RCT of an Indirect Contact Mental Health Literacy Program for 5th-Grade Students
Indirect Contact, Standard MHL Lesson Only - Mental Health Literacy, Stigma (Social Distance)
Not applicableCompletedTokyo University1282025-12-152026-07-22
Scenario-Driven Virtual Reality Game for Dementia Education Program
VR-Experienced + ASA VR Group, VR-Experienced + Standard Control Group, VR-Unexposed + ASA VR Group - Dementia
Not applicableEnrolling by invitationUniversitas Airlangga2002025-09-012025-11-20
Encapsulation-oriented vs. Timing-oriented Strategies for Necrotizing Pancreatitis
The timing of endoscopic intervention for necrotizing pancreatitis is determined based on the degree of encapsulation, EUS-guided drainage based on the interval from the onset of acute pancreatitis - Walled Off Necrosis, Pancreatitis
Not applicableNot yet recruitingTokyo University2242025-08-052025-08-06
Enhancing Healthcare Students' Attitudes Toward Dementia Care Through Virtual Reality Education
The VR dementia education group, The control group - Nursing Students, Education Program on Dementia
Not applicableCompletedUniversitas Airlangga2002024-10-142025-11-19
Early-stage Ovarian Clear Cell Carcinoma (OCCC) Patients at Risk of Recurrence
FIGO Stage IC2 to II Ovarian Clear Cell Carcinoma
UnknownNational Taiwan University Hospital2722024-03-152024-02-23
Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia
Health Education - Dementia
Not applicableCompletedUniversitas Airlangga4002023-11-222025-11-19
Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults
Fitbit wearing, with notification for sleep, activity and nutrition based fitbit data, Routine care - Cognition Disorders in Old Age, Cognitive Function
Not applicableCompletedTokyo University3552023-11-082026-04-16
WONDER-02 Trial: Plastic Stent vs. Lumen-apposing Metal Stent for Pancreatic Pseudocysts
Plastic stent, LAMS - Pancreatic Fluid Collection, Pancreatitis
Not applicableNot yet recruitingTokyo University802023-11-012023-11-15
Management and Outcomes of Local Complications of Acute Pancreatitis and Postoperative Pancreatic Fistula
Routine Clinical Management of Local Complications - Acute Pancreatitis, Pancreatic Fluid Collection
RecruitingTokyo University50002023-09-142026-10-07
Endoscopic Ultrasound-guided Rendezvous Versus Precut Papillotomy
EUS-guided rendezvous, Early precut papillotomy group - Bile Duct Diseases
Not applicableRecruitingChinese University of Hong Kong1882023-09-052026-07-16
Liver Injury After COVID-19 Vaccination
Approved COVID-19 vaccine - Subjects After COVID-19 Vaccination
CompletedHumanity & Health Medical Group Limited3792022-09-052025-03-24
Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
Immediate necrosectomy, Step-up approach - Pancreatic Fluid Collection, Walled-off Necrosis
Not applicableRecruitingTokyo University702022-07-292022-10-27
Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer
Pembrolizumab, Olaparib - Cervical Cancer
Phase 2UnknownSaitama Medical University International Medical Center282021-01-012022-08-09
The Medical Management in Patients Exposed to Weapons of Mass Destruction
Clinical interventions performed in acute settings (contaminated environment), Protection (clinician and patient), Decontamination (clinician and patient) - Chemical Injury, Chemicals; Intoxication
Enrolling by invitationSt. Justine's Hospital10002020-10-012025-10-01
Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric Cancer
AI-based diagnosis, The expert endoscopists-based diagnosis - Gastric Cancer
Not applicableCompletedTokyo University5002019-07-012019-11-20
Teacher-led MHL Education in Japanese Preteens
Short Mental Health Literacy Program (SMHLP) - Mental Health Literacy, Stigma of Mental Illness
Not applicableCompletedTokyo University14012019-06-012025-08-14
The Overall Survival of Patients With Unresectable HCC in Real-life
Hepatocellular Carcinoma
RecruitingHumanity & Health Medical Group Limited50002018-07-162025-03-24
Efficacy of Peer Counseling, Social Engagement, and Combination Interventions in Improving Depressive Symptoms of Filipino Senior Citizens
Community-based depression interventions - Depressive Symptoms
Not applicableCompletedTokyo University2702018-04-012019-06-19
A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis
Double-Blind Placebo, Double-Blind Rituximab - Scleroderma, Systemic, Skin Sclerosis
Phase 2 / Phase 3CompletedTokyo University562017-12-042020-02-18

Showing 20 of 54. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (6)  ·  Breast Neoplasms (3)  ·  Dementia (3)  ·  Depression (3)  ·  Pancreatic Pseudocyst (3)  ·  Pancreatitis (3)  ·  Stomach Neoplasms (3)  ·  Colonic Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Hypoxia-Ischemia, Brain (2)  ·  Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Pancreatitis, Acute Necrotizing (2)  ·  Psychological Well-Being (2)

Interventions

Receptor Protein-Tyrosine Kinases (8)  ·  LY6K protein, human (5)  ·  Adjuvants, Pharmaceutic (2)  ·  HLA-A*24:02 antigen (2)  ·  montanide ISA 51 (2)  ·  Continuity of Patient Care (1)  ·  Decontamination (1)  ·  Diclofenac (1)  ·  Enteral Nutrition (1)  ·  Hydrochlorothiazide (1)  ·  KIF20B protein, human (1)  ·  NUF2 protein, human (1)  ·  Parenteral Nutrition (1)  ·  RNF43 protein, human (1)  ·  Telmisartan (1)

Countries

Japan (41)  ·  Hong Kong (4)  ·  China (3)  ·  Indonesia (3)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  India (1)  ·  Malaysia (1)  ·  Nepal (1)  ·  Philippines (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Thailand (1)

Top investigators

Naohide Yamashita, MD/PhD (6)  ·  Yataro Daigo, MD, PhD (4)  ·  Masaru Shinozaki, MD/PhD (3)  ·  Yousuke Nakai (3)  ·  Dianis Wulan Sari, Ph.D (2)  ·  George Lau, MD (2)  ·  Haruo Shintaku, MD, PhD (2)  ·  Naohide Yamashita, MD, PhD (2)  ·  Ahmed Ehsanur Rahman, MPH, MBBS (1)  ·  Atsuo Yamada, MD (1)  ·  Ayumi Yoshizaki, MD, PhD (1)  ·  D M Emdadul Hoque, MPH, MBBS (1)  ·  Hirotaka Chikuda, MD, PhD (1)  ·  Hiroyuki Isayama, MD, PhD (1)  ·  Jasmin Khan, MPH, MSS (1)

Results publications

PMID 20104072, PMID 21893577, PMID 23924165, PMID 26447149, PMID 27933747, PMID 28982258, PMID 29615078, PMID 29724194, PMID 29735587, PMID 29780873, PMID 29879916, PMID 31563627, PMID 31574127, PMID 32236104, PMID 32779730, PMID 34607377, PMID 34751757, PMID 35136981, PMID 35663276, PMID 36175098, PMID 36372869, PMID 37226252, PMID 38279402, PMID 38294008, PMID 39130048, PMID 39182137, PMID 39293050, PMID 39818975, PMID 41720198, PMID 41851699, PMID 42013608, PMID 42831056